Asset Details
Do you wish to reserve the book?
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Do you wish to request the book?
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
2017
Overview
Five-year data showed that among patients with type 2 diabetes and a BMI of 27 to 43, bariatric surgery plus intensive medical therapy was more effective than intensive medical therapy alone in decreasing or resolving hyperglycemia, even among those with a BMI of less than 35.
Observational studies
1
–
6
and randomized, controlled trials, which have generally been short-term studies,
7
–
19
have shown that bariatric surgery, when used specifically to treat diabetes, significantly improves glycemic control and reduces cardiovascular risk factors. In the Surgical Treatment and Medications Potentially Eradicate Diabetes Efficiently (STAMPEDE) trial, we reported that, at 1 year and 3 years after randomization, both gastric bypass and sleeve gastrectomy were superior to intensive medical therapy alone in achieving excellent glycemic control (i.e., glycated hemoglobin ≤6.0%), reducing cardiovascular risk, improving quality of life, and decreasing medication use.
8
–
10
The current article provides results of the final, 5-year . . .
Publisher
Massachusetts Medical Society
Subject
/ Diabetes
/ Diabetes mellitus (non-insulin dependent)
/ Diabetes Mellitus, Type 2 - blood
/ Diabetes Mellitus, Type 2 - drug therapy
/ Diabetes Mellitus, Type 2 - surgery
/ Female
/ Glucose
/ Glycated Hemoglobin A - analysis
/ Humans
/ Hypoglycemic Agents - therapeutic use
/ Insulin
/ Male
/ Surgery
